Cytokine and immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of classical swine fever virus
Introduction
Classical swine fever (CSF) is a highly contagious viral disease in swine. Highly virulent CSFV strains can lead to acute haemorrhages, severe immune suppression and high mortality. CSFV is a small enveloped Pestivirus in the Flaviviridae family. Its RNA genome encodes 12 proteins, including the E2 glycoprotein, which is the most immunogenic one (Wensvoort et al., 1990).
The CP7_E2alf vaccine, a live chimera of Bovine viral diarrhoea virus (BVDV) expressing the CSFV E2 protein shows a strong potential to control CSF with the possibility to differentiate infected from vaccinated animals (Reimann et al., 2004). The CP7_E2alf vaccine is also the first efficient and safe marker vaccine candidate for oral immunization of wild boar against CSFV (Koenig et al., 2007). The CP7_E2alf marker vaccine conferred full clinical protection against a challenge with the highly virulent Koslov CSFV strain 7 days after intramuscular or 14 days after oral immunization (Leifer et al., 2009). Complete protection against a Koslov challenge was also demonstrated 21 days after oral CP7_E2alf vaccination (Blome et al., 2012). Moreover, the CP7_E2alf vaccine induces long-term immunity against a Koslov challenge, for at least 6 months after intramuscular or oral administration (Gabriel et al., 2012).
Protection from the disease is commonly associated with a humoral (Th2) immune response with the production of CSFV-specific antibodies or neutralizing antibodies (NAb) that usually appear about 2 weeks post-vaccination (pv) (van Oirschot, 2003). The duration of immunity induced by the CP7_E2alf vaccine is also attributed to stable antibody titres (Gabriel et al., 2012). Information about isotype differentiation is currently lacking for the early or late systemic antibody response (IgM/IgG differentiation), the balance of adaptive immunity toward Th1 or Th2 response (IgG1/IgG2 differentiation) or mucosal immunity (IgA detection). Partial investigation of IgG sub-class differentiation revealed that CSFV-specific IgG2 levels induced by early challenge with the moderately virulent CSFV strain were higher in CP7_E2alf orally vaccinated pigs than in unvaccinated pigs (Renson et al., 2013). No data is as yet available for IgA or IgM.
A previous study involving early challenge with a moderately virulent strain of CSFV at 2 days pv had revealed that oral CP7_E2alf vaccination interfered with pathogeny-related cytokine responses, e.g. attenuated the increase of IFN-α and IL-12 levels or the reduction of TGF-β1 level in serum (Renson et al., 2013). In this study, cytokine responses that might be influenced by CSFV infection were further investigated and immunoglobulin (Ig) G isotype profiles were completed with those for IgM and IgA, on samples obtained from different experiments, in which challenges with the highly virulent Koslov strain of CSFV had been applied later i.e., at 14 days or 6 months post-vaccination. The immune profiles obtained after oral or intramuscular immunizations were also compared. This study not only confirmed our initial results but also provided new elements about the responses induced by CP7_E2alf vaccination during the onset and duration of immunity.
Section snippets
OOI (onset of immunity) study – challenge at 14 days post-vaccination (dpv)
Serum samples, collected at 0, 4, 7, 10, 14 and 21 days post-infection or post-challenge (dpi) were kindly provided by NFCSO-DVMP from their efficacy study (unpublished study). Samples were obtained from five 6-week-old Kahyd pigs orally vaccinated with a single dose of the CP7_E2alf vaccine solution (1.6 ml at 105.6 TCID50/ml) then oronasally challenged at 14 dpv with the highly virulent Koslov strain (2 ml at 105.5 TCID50/ml). Three sera from an unvaccinated positive control group were also
Effect of CP7_E2alf vaccine on cytokine responses induced after Koslov CSFV strain infection
In the OOI study, a challenge with the highly virulent Koslov strain at 14 dpv led to an increase in the serum levels of IFN-α, TNF-α, IL-6 and IL-12 in the unvaccinated controls (Fig. 1b–e) whereas the level of TGF-β1 was reduced at 7 and 10 dpi in the last surviving pig (Fig. 1a). Prior to the challenge, no significant differences were observed in the levels of any cytokine between vaccinated pigs and unvaccinated pigs.
After challenge, the CP7_E2alf vaccination prevented the reduction of
Discussion
The role of cytokines in CSFV pathogeny or protection against CSFV infection induced by vaccination is not fully understood. In this study, the levels of the antiviral cytokine IFN-α and the cytokine coordinating innate and adaptive immune responses IL-12, were enhanced and that of the anti-inflammatory cytokine TGF-β1 reduced, following CSFV infection with the highly virulent “Koslov” strain. They were then modified by CP7_E2alf oral or i.m. vaccination. This confirms our previous results (
Acknowledgements
This work was funded by the EU Seventh Framework Programme (FP7/2007-2013) under Grant agreement no. 227003 CP-FP (project CSFV_goDIVA).
The authors thank Timea Barna, Katalin Fabian, Attila Farsang for their contribution in performing the animal experiment, collecting samples and careful correction of the manuscript.
References (31)
- et al.
Comparative evaluation of live marker vaccine candidates “CP7_E2alf” and “flc11” along with C-strain “Riems” after oral vaccination
Veterinary Microbiology
(2012) - et al.
Patterns of cellular gene expression in swine macrophages infected with highly virulent classical swine fever virus strain Brescia
Virus Research
(2008) - et al.
The immune response to bovine viral diarrhea virus: a constantly changing picture. The Veterinary Clinics of North America
Food Animal Practice
(2004) - et al.
Control of immunoglobulin isotype production by porcine B-cells cultured with cytokines
Veterinary Immunology and Immunopathology
(2003) - et al.
Use of ELISPOT and ELISA to evaluate IFN-gamma, IL-10 and IL-4 responses in conventional pigs
Veterinary Immunology and Immunopathology
(2005) - et al.
Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-duration of immunity
Vaccine
(2012) - et al.
Characterisation of vaccine-induced, broadly cross-reactive IFN-gamma secreting T cell responses that correlate with rapid protection against classical swine fever virus
Vaccine
(2012) - et al.
Characterization of conventional and plasmacytoid dendritic cells in swine secondary lymphoid organs and blood
Veterinary Immunology and Immunopathology
(2006) - et al.
Inclusion bodies from recombinant bacteria as a novel system for delivery of vaccine antigen by the oral route
Immunology Letters
(2004) - et al.
CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against classical swine fever virus (CSFV)
Vaccine
(2007)
Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization
Vaccine
Development and partial validation of a recombinant E2-based indirect ELISA for detection of specific IgM antibody responses against classical swine fever virus
Journal of Virological Methods
Clinical signs and epidemiology of classical swine fever: a review of new knowledge
Veterinary Journal (London, England: 1997)
An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus
Virology
Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs
Veterinary Microbiology
Cited by (10)
Classical swine fever in pigs: Recent developments and future perspectives
2014, Animal Health Research ReviewsClassic Swine Fever
2021, Veterinary Vaccines: Principles and ApplicationsPestiviruses
2019, Diseases of SwineEpidemiology, diagnosis and control of classical swine fever: Recent developments and future challenges
2018, Transboundary and Emerging Diseases